Hendrik is a member of our energy and natural resources sector group and advises clients in the energy sector. He has particular expertise in the area of energy litigation, energy compliance, energy-related M&A and energy regulatory issues including carbon pricing. Hendrik leads the regulatory section of the firm’s global hydrogen group.
Furthermore, Hendrik advises on all aspects of European and German competition law including merger control, cartel investigations and follow-on damages actions.
Ben is a senior associate in our intellectual property group.
Ben advises clients on IP, technology and commercial mattes, with a particular focus on the life sciences sector.
Ben's practice involves negotiating complex licensing and collaboration arrangements and other strategic alliances and advising on IP issues arising in the context of M&A, joint venture and IPOs. Ben also advises on business separation and commercial issues in the context of complex IP/tech-heavy carve-outs.
Ben's contentious experience includes the litigation and arbitration of patents, trade marks and trade secrets and IP licence disputes.
- Novartis on the separation and spin-off of Sandoz, its generics and biosimilars division.
- Ontario Teachers’ Pension Plan Board on its joint investment with Nordic Capital in Advanz Pharma.
- Hasten Biopharmaceuticals on its acquisition of the product portfolios in South East Asia from Celltrion Healthcare.
- Recordati, a portfolio company of CVC Capital Partners, on its acquisition of EUSA Pharma (UK) Limited.
- Universal Music Group on the IP aspects of its majority Investment in Mavin Global.
- EdF on the IP aspects of its acquisition of part of GE Steam Power’s nuclear power business.
- General Atlantic's BeyondNetZero on the acquisition of a minority stake in ABB E-mobility.
- AstraZeneca on its cancer drug patent licence dispute with Tesaro.
- Advising global telecoms company on a major, multi-jurisdictional SEP/FRAND dispute, including advising on client’s SEP portfolio vetting project.
